Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for bleeding reduction in elective cesarean section among moderate- and high-risk patients
IRCT20211114053061N1Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial of tranexamic acid in postpartum hemorrhage (PPH) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Bleeding volume and Blood transfusion. Started May 2021; status: completed.
02
Drugs
tranexamic acid
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on IRCT20211114053061N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211114053061N1.